시장 데이터 로딩 중...
2026년 8월 30일 일요일
LineVest LogoLineVest

LineVest

뉴스

미국 시장·금융 최신 뉴스

뉴스
KOSPI Whipsaws to 5.8% as Funds Catch Samsung, SK Hynix Dip
뉴스

KOSPI Whipsaws to 5.8% as Funds Catch Samsung, SK Hynix Dip

South Korea's benchmark KOSPI index staged one of its wildest sessions of the year on Friday, July 3, swinging from a 3.5% intraday plunge to a sharp "V-shaped"

2026.07.03.1
Hanmi Science (008930.KS) Heir Stake Tips Family Past Shin
뉴스

Hanmi Science (008930.KS) Heir Stake Tips Family Past Shin

The younger son of Hanmi's founding family has sold a 2.5% stake — roughly ₩82.07 billion ($59.9 million) worth of shares — to a fund aligned with his mother an

2026.07.03.0
Daewoo E&C Returns to US Real Estate After 20-Year Hiatus With $291M New Jersey Project
뉴스

Daewoo E&C Returns to US Real Estate After 20-Year Hiatus With $291M New Jersey Project

South Korea's Daewoo E&C returns to US real estate after a 20-year absence with a $291 million investment in Palisades Park, New Jersey, partnering with Tamares Group on an 18-story, 540-unit residential complex through its US unit DUSAI.

2026.07.03.0
KB Financial (105560.KS) Narrows Chairman Race to Six
뉴스

KB Financial (105560.KS) Narrows Chairman Race to Six

KB Financial Group (105560.KS), South Korea's largest financial holding company by market value, narrowed its chairman succession field to six candidates on Jul

2026.07.03.0
Hyundai and Kia Post Record 920,383 H1 US Sales as Hybrids Surge 65.5%, EVs Drop
뉴스

Hyundai and Kia Post Record 920,383 H1 US Sales as Hybrids Surge 65.5%, EVs Drop

Hyundai Motor and Kia delivered 920,383 vehicles in H1 2026, setting a new record as hybrid sales surged 65.5% YoY while EV deliveries fell 9.7%.

2026.07.03.2
Samsung, SK Hynix and Celltrion Pledge KRW 392 Trillion to Chungcheong in Korea's 'Second Tokyo Declaration'
뉴스

Samsung, SK Hynix and Celltrion Pledge KRW 392 Trillion to Chungcheong in Korea's 'Second Tokyo Declaration'

Samsung, SK Hynix CEO Kwak No-jeong and Celltrion commit KRW 392 trillion to Chungcheong as President Lee calls it Korea's 'second Tokyo Declaration.' Anthropic also eyes Samsung 2nm foundry.

2026.07.03.0
LG Energy Solution (373220.KS) Ohio EV Plant Pivots to ESS
뉴스

LG Energy Solution (373220.KS) Ohio EV Plant Pivots to ESS

A $3.5 billion battery plant that Honda and LG Energy Solution broke ground on to build electric-vehicle cells has instead started churning out cells for the po

2026.07.03.0
Celltrion (068270.KS) Q2: Margin 33%, Record ₩430B Profit
뉴스

Celltrion (068270.KS) Q2: Margin 33%, Record ₩430B Profit

Celltrion (068270.KS), Korea's largest biosimilar maker, said its second-quarter operating margin leapt to roughly 33% — the sharpest profitability move in the

2026.07.03.0
KOSPI Sinks 7.9% as 'Meta Shock' Routs Korean Chip Stocks
뉴스

KOSPI Sinks 7.9% as 'Meta Shock' Routs Korean Chip Stocks

KOSPI plunged 7.89% to 7,648.09 on July 2, 2026 as Meta's AI cloud plans sparked fears of AI compute overcapacity, sending SK Hynix down 14.57% and Samsung down 9.06% in a 'Black Thursday' rout.

2026.07.02.1
Seoul and Washington Clash Over ₩624.7B Coupang Fine as US House Labels Korea's Data Enforcement Discriminatory
뉴스

Seoul and Washington Clash Over ₩624.7B Coupang Fine as US House Labels Korea's Data Enforcement Discriminatory

South Korea's Foreign Ministry and NIS push back against a US House Judiciary Committee report that labels the PIPC's record ₩624.7 billion ($403 million) privacy fine against Coupang as 'discriminatory.' The fine stems from a Chinese-employee data breach exposing 37 million Coupang users.

2026.07.02.0
Google's €4.1B EU Fine Sealed, Samsung (005930.KS) in Focus
뉴스

Google's €4.1B EU Fine Sealed, Samsung (005930.KS) in Focus

On July 2, the Court of Justice of the European Union (the EU's highest court, whose rulings cannot be appealed) dismissed the final challenge from Alphabet's G

2026.07.02.2
Hanmi Pharma (128940.KS) Promotes Obesity, Licensing VPs
뉴스

Hanmi Pharma (128940.KS) Promotes Obesity, Licensing VPs

Hanmi Group, a Korean pharmaceutical group whose listed drugmaker Hanmi Pharmaceutical (128940.KS) is a KOSPI large-cap, on July 2 promoted six executives in it

2026.07.02.1